DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nilvadipine
Nilvadipine
S Values in Accordance with Soczewiński-Wachtmeisters Equation
Dorset Medicines Advisory Group
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
Antioxidant Effects of Calcium Antagonists Rat Myocardial
Download Leaflet View the Patient Leaflet in PDF Format
The Following Full Text Is a Publisher's Version
PDF-Document
Summary of Product Characteristics
Prescription Medications, Drugs, Herbs & Chemicals Associated With
Reduces Ischemic Brain Injury in Rats
Drugs and Scaffold That Inhibit Cytochrome P450 27A1 (CYP27A1) in Vitro and in Vivo
Genetic and Clinical Features of SCN8A Developmental and Epileptic Encephalopathy T
Epileptogenesis and Epilepsy
Molecular Mechanism of the Urate-Lowering Effects of Calcium Channel Blockers
Exploratory Analyses Suggest Less Cognitive Decline with Nilvadipine Treatment in Very Mild Alzheimer’S Disease Subjects
Original Articles the Effect of Nilvadipine on Bloodflow in The
NILVAD Protocol: a European Multicentre Double-Blind Placebo-Controlled Trial of Nilvadipine in Mild-To-Moderate Alzheimer’S Disease
Top View
Identifying Mutations in Epilepsy Genes Impact on Treatment Selection
Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
Medication-Related Inpatient Falls: a Critical Review
Drug Class Review on Calcium Channel Blockers
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Download Product Insert (PDF)
Effects of Nilvadipine on Cerebral Blood Flow in Patients with Alzheimer Disease a Randomized Trial
United States Patent (19) 11 Patent Number: 5,834,496 Young (45) Date of Patent: Nov
What Kinds of Patients Requires Prophylactic Therapy?
Lorazepam Losartan Potassium Loxoprofen Sodium Hydrate
A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
Differential Effects of Antihypertensive Drugs with Differing Pharmacological Properties on the Basal Ambulatory Blood Pressure
Prediction of Human Systemic, Biologically Relevant Pharmacokinetic Properties Based on Physicochemical Properties of Calcium Channel Blockers
Autophagy Stimulation As a Promising Approach in Treatment of Neurodegenerative Diseases
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Drug Class Review on Calcium Channel Blockers
Amlodipine - a Third Generation Dihydropyridine Calcium Antagonist
Comparison of the Utility of RP-TLC Technique and Different
Blocking T-Type Ca2+ Channels with Efonidipine Decreased Plasma Aldosterone Concentration in Healthy Volunteers
202611Orig1s000
Tepzz 8 Z66zb T
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Mix-Up of Drugs Due to Similarity of Nonproprietary Names
Neuroprotective Effects of Nicardipine in a Rat Model of Ischemia and Reperfusion
Calcium Channel Blockers (Dihydropyridine Derivatives) for the Treatment of Hypertension and Stable Angina
Drug Safety Newsletter-Issue No. 3-January 1997
Attempts and Outcomes of Liquisolid Technology: an Updated Chronological Compilation of Innovative Ideas and Adjuvants in the Field
(12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Antiepileptic Drug Interactions